Internal Server Error

About Brooks Hill Partners

Brooks Hill Partners is a venture capital firm founded in 2018. It is primarily based out of Waltham, United States. As of Jan 2023, Brooks Hill Partners has invested in 14 companies. It primarily invests in Seed round in United States based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to Consumer and Life Sciences. Most recently it participated in the $***** Seed round of Cellbricks Overall, Brooks Hill Partners portfolio has seen 1 unicorn and 4 acquisitions including key companies like Wasabi, Deep 6 AI and 3Derm. Brooks Hill Partners has team of 2 people including 1 partners.
Key Metrics
Team Members
Portfolio Count
Portfolio Locations
Rounds of Entry
Seed
Portfolio Acquisitions
Portfolio Unicorns

Brooks Hill Partners' List of Top Investments

Brooks Hill Partners has a portfolio of 14 companies, one of which is a Unicorn. Their most notable investmentis in CellbricksTheir portfolio spans across United States, Germany and India. They have invested in Enterprise Applications, Consumer, Life Sciences and 6 other sectors, across stages such as Seed stage. Here is the list of top investments by Brooks Hill Partners:
Cloud storage provider offering scalable solution for businesses. It allows to store and manage the data. It offers solutions such as backuo and recovery, media workflows, active archiving, multi-tenant management, and more.

Key facts about Wasabi

Deep 6 AI (formerly Deep 6 Analytics) develops artificial intelligence enabled solutions for clinical trial use cases. It uses AI technologies to understand the unstructured data from medical records to find more patients for clinical trials easily. It helps hospitals or pharma companies to reduce the onboarding and trail time, reduce record analysis expenses, increase patient outcome, etc.

Key facts about Deep 6 AI

Astrocyte Pharmaceuticals is a small drug development company focussed on developing neuroprotection therapies for brain injury, concussions, stroke, and neurodegenerative disorders. It is developing its drugs that can activate astrocyte, a cell of the CNS that has the potential to treat CNS disorders such as brain injury, stroke, Alzheimer’s Disease.

Key facts about Astrocyte Pharmaceuticals

  • Founded Year: 2014
  • Location: Cambridge (United States)
  • Stage: Series A
  • Total Funding till date: $15.9M
  • Employee Count: 12 as on Jul 31, 2026
  • Investors: UT System, Dreavent and 14 Others
  • Latest Funding Round: Grant (prize money), Jun 10, 2025, $*****
  • Highlight: Editors' Pick
Application based platform offering mobile CRM. The platform offers clients business mobile numbers. Its number enables customers to connect with their business. The calls between customers and clients teams are auto recorded. Clients can review all the calls using its app. Its features include sharing a business card, catalog, location, payment link, website, etc., from the call screen itself, adding customer tags, notes about sales inquiries, reminders, etc.

Key facts about SuperFone

Digital skin image analysis and disease detection tool for providers. With 3Derm, dermatologists can review images taken at medical kiosks and other referral sites to efficiently monitor high volumes of patients’ lesions while reserving in-office appointment times for those patients whose images indicate a more alarming condition.

Key facts about 3Derm

Brooks Hill Partners' Investments by Stage

Brooks Hill Partners has made 1 investment in Seed stage.

Brooks Hill Partners' Investments by Sector

Brooks Hill Partners has a diverse portfolio, with companies operating in the High Tech, Industrial Goods and Manufacturing and Life Sciences. Notably, it has invested in 13 Tech companies, 12 Enterprise (B2B) companies, 10 Software companies and at least 5 companies focusing on Saas.
Here are Brooks Hill Partners' investments by sector:
Sector
No. of Investments
High Tech
1
Industrial Goods and Manufacturing
1
Life Sciences
1
Breakdown of Brooks Hill Partners' investments by sectorsHigh Tech (1)Industrial Goods ... (1)
Note: We have considered here, only first round of investments

Brooks Hill Partners' Investments by Geography

Brooks Hill Partners has made most investments in Germany (1).

Brooks Hill Partners' recent investments

Brooks Hill Partners has not made any investment in 2026 so far.
Here are the most recent investments by Brooks Hill Partners:
Date
Company
Location
Round Details
Round Amount
Co-Investors
Jan 26, 2023
Germany
Seed
7641
-
-
United States
Seed
9256
-
-
United States
Seed
1826
-

Unicorns in Brooks Hill Partners' Portfolio

Brooks Hill Partners has 1 unicorn in its portfolio - Wasabi. The most recent unicorn in their portfolio is Wasabi which became a unicorn in 2022, 3 years before Brooks Hill Partners first invested in it.
Here is a list of unicorns in Brooks Hill Partners' portfolio:
Tracxn Score
Company
Short Description
Founded year
Sector
Location
Company Stage
First Investment/ Acquisition Details
71
Cloud storage provider offering scalable solution for businesses
2015
Boston
Series E
tjpzuwy

Acquired companies in Brooks Hill Partners' Portfolio

4 companies from Brooks Hill Partners' portfolio have been acquired. The most recent acquisition was Deep 6 AI in Mar 2025 by Tempus for $*****.
Here are Brooks Hill Partners' portfolio companies that got acquired most recently:
Company
Acquisition Date
First Invested on
First Round of Investment
Round Size
Mar 11, 2025
-
-
9221
Jun 14, 2021
-
-
4728
Aug 20, 2020
-
-
9668
Aug 19, 2020
-
-
6746

Team profile of Brooks Hill Partners

Brooks Hill Partners has a team of 2 members located in United States. Brooks Hill Partners' team does not sit on the board of any company as of now.

Co-investors of Brooks Hill Partners

Over the past 3 years, one investor has co-invested in Brooks Hill Partners's portfolio companies. This includes funds and angels.

Recent News related to Brooks Hill Partners

View all news related to Brooks Hill Partners

FAQs about Brooks Hill Partners

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford